Literature DB >> 11801396

A quantitative study of bioenergetics in skeletal muscle lacking utrophin and dystrophin.

M A Cole1, J A Rafael, D J Taylor, R Lodi, K E Davies, P Styles.   

Abstract

Muscle energetics and function were investigated in the hindlimb of mice lacking dystrophin (mdx), utrophin and dystrophin (utr-dys) and controls (C57Bl/10) using 31P and 1H magnetic resonance techniques, electrical nerve stimulation and direct biochemical analysis. At rest, [adenosine triphosphate] and [total creatine] were lowest in utr-dys, while [inorganic phosphate] was elevated. Calculated [adenosine diphosphate] was 3-fold higher in mdx and 5-fold higher in utr-dys than in controls, consistent with an increased adenosine triphosphate requirement for ion pump activity. During stimulation, force production was low only in utr-dys, and this was reflected in the bioenergetic changes. Initial recovery rates of [phosphocreatine] and [adenosine diphosphate] after stimulation were rapid in all groups, indicative of normal mitochondrial adenosine triphosphate production in utr-dys and mdx. Recovery of pH was slow in utr-dys. The data indicate that the severe abnormalities which are present in the absence of utrophin and dystrophin leave basic muscle energetics intact and appear confined to processes involving the sarcolemma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11801396     DOI: 10.1016/s0960-8966(01)00278-4

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  22 in total

Review 1.  In vivo MR investigation of skeletal muscle function in small animals.

Authors:  B Giannesini; P J Cozzone; D Bendahan
Journal:  MAGMA       Date:  2004-12-10       Impact factor: 2.310

2.  Proteomic assessment of the acute phase of dystrophin deficiency in mdx mice.

Authors:  D Gardan-Salmon; J M Dixon; S M Lonergan; J T Selsby
Journal:  Eur J Appl Physiol       Date:  2011-03-16       Impact factor: 3.078

3.  Immunoproteasome in animal models of Duchenne muscular dystrophy.

Authors:  Chiao-Nan Joyce Chen; Ted G Graber; Wendy M Bratten; Deborah A Ferrington; LaDora V Thompson
Journal:  J Muscle Res Cell Motil       Date:  2014-06-17       Impact factor: 2.698

4.  Oral quercetin administration transiently protects respiratory function in dystrophin-deficient mice.

Authors:  Joshua T Selsby; Christopher G Ballmann; Hannah R Spaulding; Jason W Ross; John C Quindry
Journal:  J Physiol       Date:  2016-05-29       Impact factor: 5.182

Review 5.  Nitric oxide synthase deficiency and the pathophysiology of muscular dystrophy.

Authors:  James G Tidball; Michelle Wehling-Henricks
Journal:  J Physiol       Date:  2014-09-05       Impact factor: 5.182

6.  Loss of positive allosteric interactions between neuronal nitric oxide synthase and phosphofructokinase contributes to defects in glycolysis and increased fatigability in muscular dystrophy.

Authors:  Michelle Wehling-Henricks; Meredith Oltmann; Chiara Rinaldi; Kyu H Myung; James G Tidball
Journal:  Hum Mol Genet       Date:  2009-06-19       Impact factor: 6.150

7.  Defects in mitochondrial ATP synthesis in dystrophin-deficient mdx skeletal muscles may be caused by complex I insufficiency.

Authors:  Emma Rybalka; Cara A Timpani; Matthew B Cooke; Andrew D Williams; Alan Hayes
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

8.  Combined MRI and ³¹P-MRS investigations of the ACTA1(H40Y) mouse model of nemaline myopathy show impaired muscle function and altered energy metabolism.

Authors:  Charlotte Gineste; Yann Le Fur; Christophe Vilmen; Arnaud Le Troter; Emilie Pecchi; Patrick J Cozzone; Edna C Hardeman; David Bendahan; Julien Gondin
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

9.  Applications of metabolomics and proteomics to the mdx mouse model of Duchenne muscular dystrophy: lessons from downstream of the transcriptome.

Authors:  Julian L Griffin; Christine Des Rosiers
Journal:  Genome Med       Date:  2009-03-25       Impact factor: 11.117

10.  Multimodal MRI and (31)P-MRS investigations of the ACTA1(Asp286Gly) mouse model of nemaline myopathy provide evidence of impaired in vivo muscle function, altered muscle structure and disturbed energy metabolism.

Authors:  Charlotte Gineste; Guillaume Duhamel; Yann Le Fur; Christophe Vilmen; Patrick J Cozzone; Kristen J Nowak; David Bendahan; Julien Gondin
Journal:  PLoS One       Date:  2013-08-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.